Enlivex Ltd.

Healthcare · Biotechnology · Israel

Last price 2.54 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 3.16M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Enlivex Ltd., together with its subsidiaries, operates as a clinical-stage macrophage reprogramming immunotherapy company in Israel. It offers AllocetraTM, a cell therapy designed to restore macrophage homeostasis, as well as develops AllocetraTM intra-articular injection for the treatment of knee osteoarthritis, which is in phase 1/2 trial; intra-articular AllocetraTM in osteoarthritis of the temporomandibular joint (TMJ); and Allocetra-OTS for the treatment of organ failure in adult sepsis patients, which is in phase 2. Enlivex Ltd. was forme...